Literature DB >> 8088329

Induction of clonal anergy by oral administration of staphylococcal enterotoxin B.

K Migita1, A Ochi.   

Abstract

The staphylococcal enterotoxin is a major cause of food poisoning. The bacterial substance stimulates T cells expressing specific V beta T cell receptors (TcR) and is termed "the superantigen". We have previously demonstrated that intravenous injection of staphylococcal enterotoxin B (SEB) induces functional unresponsiveness (anergy) of reactive T cells as well as a partial deletion by activation-induced programmed cell death. In the present study, we examined the effect of oral administration of SEB in mice. Our results indicate that spleen T cells from SEB-primed mice are hyporesponsive to SEB stimulation in vitro, but the response to SEA was normal. V beta 8+ T cells purified from SEB-primed mice did not respond to stimulation of TcR. This SEB-specific unresponsiveness could not be reversed by exogenous interleukin-2, but was partially reversed by phorbol 12-myristate 13-acetate. Activation of mitogen-activated protein kinase during TcR-mediated stimulation was significantly inhibited in anergic T cells. Although the mechanisms of oral tolerance are not well understood, these results show that oral administration of SEB induce clonal anergy in peripheral T cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8088329     DOI: 10.1002/eji.1830240922

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Effect of multiple antigenic exposures in the gut on oral tolerance and induction of antibacterial systemic immunity.

Authors:  S Garg; V Bal; S Rath; A George
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model.

Authors:  B G Stiles; A R Garza; R G Ulrich; J W Boles
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

3.  Activation of bovine lymphocyte subpopulations by staphylococcal enterotoxin C.

Authors:  W A Ferens; W C Davis; M J Hamilton; Y H Park; C F Deobald; L Fox; G Bohach
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

4.  Mucosal tolerance to a bacterial superantigen indicates a novel pathway to prevent toxic shock.

Authors:  L Vincent Collins; Kristina Eriksson; Robert G Ulrich; Andrej Tarkowski
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

5.  Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).

Authors:  M Nielsen; A Svejgaard; C Röpke; M Nordahl; N Odum
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

6.  Regulatory T cells modulate staphylococcal enterotoxin B-induced effector T-cell activation and acceleration of colitis.

Authors:  Armando Heriazon; Pengfei Zhou; Rajka Borojevic; Katharina Foerster; Catherine J Streutker; Terry Ng; Kenneth Croitoru
Journal:  Infect Immun       Date:  2008-12-08       Impact factor: 3.441

7.  Impaired plasma membrane targeting of Grb2-murine son of sevenless (mSOS) complex and differential activation of the Fyn-T cell receptor (TCR)-zeta-Cbl pathway mediate T cell hyporesponsiveness in autoimmune nonobese diabetic mice.

Authors:  K Salojin; J Zhang; M Cameron; B Gill; G Arreaza; A Ochi; T L Delovitch
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

8.  Transcytosis of staphylococcal superantigen toxins.

Authors:  A R Hamad; P Marrack; J W Kappler
Journal:  J Exp Med       Date:  1997-04-21       Impact factor: 14.307

9.  Staphylococcal enterotoxin B administration in pregnant rats alters the splenic lymphocyte response in adult offspring rats.

Authors:  Ping Zhou; Xin-Sheng Zhang; Zhi-Ben Xu; Shu-Xian Gao; Qing-Wei Zheng; Ming-Zhu Xu; Lin Shen; Feng Yu; Jun-Chang Guan
Journal:  BMC Microbiol       Date:  2017-01-03       Impact factor: 3.605

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.